Hospital-Initiated Smoking Cessation Among Patients Admitted with Behavioral Health Conditions.
Autor: | Cruvinel E; Department of Population Health, University of Kansas Medical Center, Kansas City, KS, USA. ecruvinel@kumc.edu., Mussulman L; Department of Population Health, University of Kansas Medical Center, Kansas City, KS, USA., Scheuermann T; Department of Population Health, University of Kansas Medical Center, Kansas City, KS, USA., Shergina E; Department of Biostatistics & Data Science, University of Kansas Medical Center, Kansas City, KS, USA., He J; Department of Biostatistics & Data Science, University of Kansas Medical Center, Kansas City, KS, USA., Sherman S; Department of Population Health, New York University School of Medicine, New York, NY, USA., Harrington K; Division of Pulmonary, Allergy and Critical Care Medicine, Department of Medicine, School of Medicine, University of Alabama at Birmingham, Birmingham, AL, USA., Rigotti NA; Department of Medicine, Harvard Medical School, Boston, MA, USA., Tindle H; Department of Medicine, Vanderbilt University School of Medicine, Nashville, TN, USA., Zhu SH; Department of Family Medicine and Public Health, University of California, San Diego, CA, USA., Richter K; Department of Population Health, University of Kansas Medical Center, Kansas City, KS, USA. |
---|---|
Jazyk: | angličtina |
Zdroj: | Journal of general internal medicine [J Gen Intern Med] 2024 Jun; Vol. 39 (8), pp. 1423-1430. Date of Electronic Publication: 2024 Feb 07. |
DOI: | 10.1007/s11606-024-08646-5 |
Abstrakt: | Background: Smoking rates among people living with behavioral health conditions (BHC) range from 30 to 65% and are 2-4 times higher than rates found in the general population. Starting tobacco treatment during a hospital stay is effective for smoking cessation, but little is known regarding treatment response among inpatients with BHC. Objective: This study pooled data across multiple clinical trials to determine the relative success in quitting among participants with BHC compared to other study participants. Participants: Adults who smoke (≥ 18 years old) from five hospital-based smoking cessation randomized clinical trials. Design: A retrospective analysis using data from the electronic health record to identify participants with primary diagnoses related to BHC. Recruitment and data analysis were conducted from 2011 to 2016. We used propensity score matching to pair patients with BHC to those with similar characteristics and logistic regression to determine differences between groups. Measures: The main outcome was self-reported 30-day abstinence 6 months post-discharge. Results: Of 6612 participants, 798 patients had a BHC-related primary diagnosis. The matched sample included 642 pairs. Nearly 1 in 3 reported using tobacco medications after hospitalization, with no significant difference between patients with and without BHC (29.3% vs. 31.5%; OR (95% CI) = 0.90 (0.71, 1.14), p = 0.40). Nearly 1 in 5 patients with BHC reported abstinence at 6 months; however, their odds of abstinence were 30% lower than among people without BHC (OR (95% CI) = 0.70 (0.53,0.92), p = 0.01). Conclusion: When offered tobacco treatment, hospitalized patients with BHC were as likely as people without BHC to accept and engage in treatment. However, patients with BHC were less likely to report abstinence compared to those without BHC. Hospitals are a feasible and promising venue for tobacco treatment among inpatients with BHC. More studies are needed to identify treatment approaches that help people with BHC achieve long-term abstinence. (© 2024. The Author(s), under exclusive licence to Society of General Internal Medicine.) |
Databáze: | MEDLINE |
Externí odkaz: |